Can we predict T cell specificity with digital biology and machine learning?
Recent advances in machine learning and experimental biology have offered breakthrough
solutions to problems such as protein structure prediction that were long thought to be …
solutions to problems such as protein structure prediction that were long thought to be …
The vaccine world of COVID-19: India's Contribution
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) eruption has left not
only illness and mortality in its wake, but also an overwhelming threat to health policy …
only illness and mortality in its wake, but also an overwhelming threat to health policy …
Population antibody responses following COVID-19 vaccination in 212,102 individuals
Population antibody surveillance helps track immune responses to COVID-19 vaccinations
at scale, and identify host factors that may affect antibody production. We analyse data from …
at scale, and identify host factors that may affect antibody production. We analyse data from …
mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses …
JS Buhre, T Pongracz, I Künsting, AS Lixenfeld… - Frontiers in …, 2023 - frontiersin.org
Background The new types of mRNA-containing lipid nanoparticle vaccines BNT162b2 and
mRNA-1273 and the adenovirus-based vaccine AZD1222 were developed against SARS …
mRNA-1273 and the adenovirus-based vaccine AZD1222 were developed against SARS …
Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19
ES Ford, K Mayer-Blackwell, L Jing, KJ Laing… - Nature …, 2024 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) hybrid immunity is more
protective than vaccination or previous infection alone. To investigate the kinetics of spike …
protective than vaccination or previous infection alone. To investigate the kinetics of spike …
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in …
Background WHO has identified Marburg virus as an emerging virus requiring urgent
vaccine research and development, particularly due to its recent emergence in Ghana. We …
vaccine research and development, particularly due to its recent emergence in Ghana. We …
Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients
T Thomson, M Prendecki, S Gleeson, P Martin… - …, 2022 - thelancet.com
Background Solid organ transplant recipients have attenuated immune responses to SARS-
CoV-2 vaccines. In this study, we report on immune responses to 3rd-(V3) and 4th-(V4) …
CoV-2 vaccines. In this study, we report on immune responses to 3rd-(V3) and 4th-(V4) …
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough …
MI Azeem, AK Nooka, U Shanmugasundaram… - Blood cancer …, 2023 - AACR
Patients with multiple myeloma (MM) mount suboptimal neutralizing antibodies (nAb)
following 2 doses of SARS-CoV-2 mRNA vaccines. Currently, circulating SARS-CoV-2 …
following 2 doses of SARS-CoV-2 mRNA vaccines. Currently, circulating SARS-CoV-2 …
Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian …
This proof-of-concept study tested if prior BCG revaccination can qualitatively and
quantitively enhance antibody and T-cell responses induced by Oxford/AstraZeneca …
quantitively enhance antibody and T-cell responses induced by Oxford/AstraZeneca …
Immunogenicity, efficacy and safety of COVID-19 vaccines: an update of data published by 31 December 2021
K Xu, C Fan, Y Han, L Dai, GF Gao - International Immunology, 2022 - academic.oup.com
The unprecedented coronavirus disease 2019 (COVID-19) pandemic has caused a disaster
for public health in the last 2 years, without any sign of an ending. Various vaccines were …
for public health in the last 2 years, without any sign of an ending. Various vaccines were …